About: Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2000 (uk) im Juli 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2000 (ast) scientific article published on 01 July 2000 (en)
publication date	wds:Q74266383-73F2EED6-F5FF-4BA7-9541-9EAC1242AC7C
publication date	2000-07-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q74266383-0C246DA8-EA68-4F52-A572-0D6B4BC51301 wds:Q74266383-1476B90E-67FF-481F-BC39-B3C3F04032AF wds:Q74266383-8E038944-1E36-4106-A641-D23981A3B316 wds:Q74266383-A5E6657F-AA04-4B16-8A11-F358448E9000
author name string	A T Hattersley M Shepherd R J Corrall W G Liddell
rdfs:label	Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes (en) Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes (nl)
skos:prefLabel	Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes (en) Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes (nl)
name	Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes (en) Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes (nl)
author	wds:Q74266383-5A2BD4BC-0660-4CD2-B2BC-1261E088E905
author	Ewan Pearson
title	wds:Q74266383-C240E84A-334B-4038-93F7-A34CD799305B
title	Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes (en)
page(s)	wds:Q74266383-75C091CF-7D6B-4FAC-A01B-1783970F0B46
page(s)	543-545
instance of	wds:Q74266383-7DB51DBD-9300-4CE2-BEB0-9A0C0A008E88
instance of	scholarly article
PubMed ID	wds:Q74266383-4C286839-95BF-4A3B-975D-834CD251418E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10972586
PubMed ID	10972586
published in	wds:Q74266383-091EEDD2-3975-4950-9596-7377F12D72B0
published in	Diabetic Medicine
issue	wds:Q74266383-593B780D-0E79-4841-A8C5-A0ADBC81A06A
volume	wds:Q74266383-E5700BD6-5877-4C8E-86D4-5BB21DF0C6E6
issue	7
volume	17
DOI	wds:Q74266383-8044F7EC-EEC6-4174-9CB2-02D6E1F7837F
DOI	http://dx.doi.org/10.1046/J.1464-5491.2000.00305.X
DOI	10.1046/J.1464-5491.2000.00305.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74266383
is cites work of	Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient Genetic cause of hyperglycaemia and response to treatment in diabetes Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4α mutations in a large European collection β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1α)-deficient mice Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors First UK survey of paediatric type 2 diabetes and MODY Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young Investigating maturity onset diabetes of the young. Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry. The role of transcription factors in maturity-onset diabetes of the young Pharmacogenetics of Anti-Diabetes Drugs The search for type 2 diabetes genes Genetic susceptibility to type 2 diabetes and implications for therapy The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes Distinct regulation of hepatic nuclear factor 1alpha by NKX6.1 in pancreatic beta cells Personalized medicine in diabetes mellitus: current opportunities and future prospects β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment Clinical features and treatment of maturity onset diabetes of the young (MODY). Novel genetic findings applied to the clinic in type 2 diabetes Pharmacogenetics of glucose-lowering drug treatment: a systematic review Pharmacogenetics and personalized treatment of type 2 diabetes Precision diabetes: learning from monogenic diabetes Characteristics of maturity onset diabetes of the young in a large diabetes center Clinically-Defined Maturity Onset Diabetes of the Young in Omanis: Absence of the common Caucasian gene mutations Development of an economic evaluation of diagnostic strategies: the case of monogenic diabetes Common and rare forms of diabetes mellitus: towards a continuum of diabetes subtypes Undiagnosed MODY: Time for Action When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes The dawn of prospective pharmacogenetic testing in type 2 diabetes Gene-specific function prediction for non-synonymous mutations in monogenic diabetes genes Human islets expressing HNF1A variant have defective β cell transcriptional regulatory networks. New insights from monogenic diabetes for "common" type 2 diabetes Searching for type 2 diabetes genes: prospects in pharmacotherapy Genetic Counseling for Diabetes Mellitus Monogenic models: what have the single gene disorders taught us? Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial Monogenic Diabetes in Children and Adolescents: Recognition and Treatment Options. Use of oral antidiabetic drugs in the treatment of maturity-onset diabetes of the young: A mini review. Acquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management. Search for genetic determinants of sulfonylurea efficacy in type 2 diabetic patients from China. Patient profiling in diabetes and role of canagliflozin Hidden MODY-Looking for a Needle in a Haystack. Genetic determinants predicting efficacy of glucose-lowering drugs?: a long way to go ... Response to oral gliclazide in a pre-pubertal child with hepatic nuclear factor-1 alpha maturity onset diabetes of the young Monogenic diabetes and pregnancy Early onset of liver steatosis in a Japanese girl with maturity-onset diabetes of the young type 3 (MODY3). Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes? Mutations in HNF1A Gene are not a Common Cause of Familial Young-Onset Diabetes in Iran. Economics of Genetic Testing for Diabetes [Childhood-onset diabetes treated with sulphonylureas] Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment HNF1A mutation in a Thai patient with maturity-onset diabetes of the young: A case report
is cites work of	wds:Q35279552-37D209EF-5A7B-42C0-8188-D1EA56C9F128 wds:Q36691238-C63CA5C7-FE17-4D5C-A974-3980B7A5FA90

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software